The combined effect of the BPI protein (bactericidal/permeability-increasing protein) and hyaluronic acid has proven effective for the treatment of arthropathies. It may integrate or replace current anti-inflammatory therapies that at times have serious side effects.
This pharmaceutical combination that contains bactericidal/permeability-increasing protein (BPI) and hyaluronic acid (HA), was created to treat different kinds of arthropathies, which are common causes of disability in Europe and in the Unites States. Hence the interest in new drug treatments that combine therapeutical efficacy and lack of side effects. BPI is a powerful antimicrobial protein that is produced naturally by different human cells, and is released in extra cellular fluids. It has anti-infective properties and demonstrated anti-inflammatory and anti-angiogenic effects. Hyaluronic acid is a polysaccharide that has anti-inflammatory, analgesic and chondroprotective properties. In vivo and in vitro studies have demonstrated better results of the combination of the two, compared to their use separately.

TRL (Technology Readiness Level)

Lead Optimization

Inventors

Leonardo Punzi

Anna Scanu

Roberto Luisetto

Download the brochure

  • SenSyTool – Sea sentinels System: A tool for monitoring PFAS-induced toxic effects

    Sea Sentinels System (S.S.S.) offers a kit consisting of 5 cell lines, obtained from tissues (muscle and skin) belonging to 3 species of marine mammals (Tursiops truncatus, Ziphius cavirostris and Grampus griseus); kept viable by cryopreservation and easily rearing in...

  • PERFUSE: peripheral arterial perfusion cannula

    Extracorporeal circulation is the only method used during cardiovascular surgery and requires the use of cannulas which are inserted into the arterial vessels: the cannulas on the market are unidirectional and only allow blood flow towards the heart. Especially in...

  • Method for the automatic tracking of the fascial system displacement in ultrasound videos for objective site-specific evaluation and personalized treatment planning and prevention

    The proposed algorithm has the capability to qualitatively and quantitatively evaluate the gliding between the multiple substrates of the fascial system as a biomarker for a variety of different clinical conditions (e.g. low back pain) before-during-after treatment and in follow-up....

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation